123 related articles for article (PubMed ID: 30890818)
1. Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population.
Fiaz M; Shaiq PA; Raj GK; Saqlain M; Mehmood A; Naqvi SMS; Cheung BK
J Pak Med Assoc; 2019 Mar; 69(3):301-305. PubMed ID: 30890818
[TBL] [Abstract][Full Text] [Related]
2. The APOA5-rs662799 Polymorphism Is a Determinant of Dyslipidemia in Vietnamese Primary School Children.
Hanh NTH; Nhung BT; Hop LT; Tuyet LT; Dao DTA; Thu NTT; Binh TQ
Lipids; 2020 Nov; 55(6):683-691. PubMed ID: 32777089
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
4. Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.
Hechmi M; Dallali H; Gharbi M; Jmel H; Fassatoui M; Ben Halima Y; Bahri S; Bahlous A; Abid A; Jamoussi H; Barakat A; Kefi R
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725151
[TBL] [Abstract][Full Text] [Related]
5. Genetic Association of Apolipoprotein A5-1131T>C Polymorphism with Traits of Metabolic Syndrome.
Zafar U; Khaliq S; Lone KP
J Coll Physicians Surg Pak; 2019 Jul; 29(7):626-630. PubMed ID: 31253212
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population.
Kefi R; Hechmi M; Dallali H; Elouej S; Jmel H; Halima YB; Nagara M; Chargui M; Fadhel SB; Romdhane S; Kamoun I; Turki Z; Abid A; Bahri S; Bahlous A; Gomis R; Baraket A; Grigorescu F; Normand C; Jamoussi H; Abdelhak S
Ann Endocrinol (Paris); 2017 Jul; 78(3):146-155. PubMed ID: 28624160
[TBL] [Abstract][Full Text] [Related]
8. Variants in APOA5 and ADIPOQ Moderate Improvements in Metabolic Syndrome during a One-Year Lifestyle Intervention.
Lowry DE; Fenwick PH; Roke K; Jeejeebhoy K; Dhaliwal R; Brauer P; Royall D; Tremblay A; Klein D; Mutch DM
Lifestyle Genom; 2018; 11(2):80-89. PubMed ID: 30472712
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
[TBL] [Abstract][Full Text] [Related]
10. APOA5 Variant rs662799, Role in Cardiovascular Traits and Serum Adipokine Levels in Caucasian Obese Subjects.
de Luis DA; Izaola O; Primo D; Aller R
Ann Nutr Metab; 2021; 77(5):299-306. PubMed ID: 34350864
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
13. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
14. Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese.
Ong KL; Jiang CQ; Liu B; Jin YL; Tso AW; Tam S; Wong KS; Tomlinson B; Cheung BM; Lin JM; Yue XJ; Lam KS; Lam TH; Thomas GN
Clin Endocrinol (Oxf); 2011 Feb; 74(2):206-13. PubMed ID: 21054477
[TBL] [Abstract][Full Text] [Related]
15. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
16. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
17. A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia.
Aghasizadeh M; Zare-Feyzabadi R; Kazemi T; Avan A; Ferns GA; Esmaily H; Miri-Moghaddam E; Ghayour-Mobarhan M
Gene; 2021 May; 782():145525. PubMed ID: 33636293
[TBL] [Abstract][Full Text] [Related]
18. Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population.
Lin E; Kuo PH; Liu YL; Yang AC; Kao CF; Tsai SJ
Sci Rep; 2016 Nov; 6():36830. PubMed ID: 27827461
[TBL] [Abstract][Full Text] [Related]
19. The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women.
Wang Y; Lu Z; Zhang J; Yang Y; Shen J; Zhang X; Song Y
Lipids Health Dis; 2016 Sep; 15(1):170. PubMed ID: 27716220
[TBL] [Abstract][Full Text] [Related]
20. Habitual aerobic exercise, gene APOA5 named rs662799 SNP and response of blood lipid and lipoprotein phenotypes among older Chinese adult.
Liu X; Huang G; Niu Z; Wei Y; Wang R
Exp Gerontol; 2018 Sep; 110():46-53. PubMed ID: 29758349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
